المؤلفون: Maor Y; Infectious Disease Unit, Wolfson Medical Center, Holon, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Shinar E; Magen David Adom, National Blood Services, Ramat Gan, Israel., Izak M; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Magen David Adom, National Blood Services, Ramat Gan, Israel., Rahav G; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Infectious Disease Unit, Sheba Medical Center, Ramat Gan, Israel., Brosh-Nissimov T; Infectious Diseases Unit, Samson Assuta Ashdod University Hospital, Ashdod, Israel.; Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er-Sheva, Israel., Kessler A; Department of Medicine, Hadassah Medical Center, Jerusalem, Israel.; Faculty of Medicine, Hebrew University and Hadassah, Jerusalem, Israel., Rahimi-Levene N; Blood Bank, Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel., Benin-Goren O; General Medical Directorate, Ministry of health, Jerusalem, Israel., Cohen D; School of Public Health, Tel Aviv University, Tel Aviv, Israel., Zohar I; Infectious Disease Unit, Wolfson Medical Center, Holon, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Alagem N; KAMADA, Rehovot, Israel., Castro S; KAMADA, Rehovot, Israel., Zimhony O; Faculty of Medicine, Hebrew University and Hadassah, Jerusalem, Israel.; Infectious Diseases Unit, Kaplan Medical Center, Rehovot, Israel.

المصدر: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Oct 05; Vol. 77 (7), pp. 964-971.

نوع المنشور: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/therapy, Humans ; Middle Aged ; Aged ; SARS-CoV-2 ; Immunization, Passive/adverse effects ; Treatment Outcome ; COVID-19 Serotherapy ; Immunoglobulins